These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26203609)

  • 41. Once-daily glycopyrronium bromide (Seebri Breezhaler(®)) for the treatment of chronic obstructive pulmonary disease (COPD).
    Ulrik CS
    Expert Opin Pharmacother; 2015; 16(17):2653-9. PubMed ID: 26641535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in pharmacotherapy for dyspnea in COPD.
    Raghavan N; Webb K; Amornputtisathaporn N; O'Donnell DE
    Curr Opin Pharmacol; 2011 Jun; 11(3):204-10. PubMed ID: 21450522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attitudes of patients with chronic breathlessness towards treatment with opioids.
    Verberkt CA; van den Beuken-van Everdingen MHJ; Wouters EFM; Janssen DJA
    Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31699842
    [No Abstract]   [Full Text] [Related]  

  • 44. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
    Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
    Szmidt M
    Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Excess Ventilation in Chronic Obstructive Pulmonary Disease-Heart Failure Overlap. Implications for Dyspnea and Exercise Intolerance.
    Rocha A; Arbex FF; Sperandio PA; Souza A; Biazzim L; Mancuso F; Berton DC; Hochhegger B; Alencar MCN; Nery LE; O'Donnell DE; Neder JA
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1264-1274. PubMed ID: 28665692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
    Lee TM; Lin MS; Chang NC
    Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
    Smallwood N; Le B; Currow D; Irving L; Philip J
    Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.
    Janssen DJ; de Hosson SM; bij de Vaate E; Mooren KJ; Baas AA
    Chron Respir Dis; 2015 May; 12(2):85-92. PubMed ID: 25676931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic obstructive pulmonary disease: the evidence for use of tiotropium.
    Burns G; Bianchi S
    Br J Hosp Med (Lond); 2006 Feb; 67(2):85-91. PubMed ID: 16498916
    [No Abstract]   [Full Text] [Related]  

  • 51. Acupuncture for dyspnea on exertion in chronic obstructive pulmonary disease: no blindness.
    Mommaerts JL; Vandevoorde J; Devroey D
    Arch Intern Med; 2012 Dec; 172(22):1772-3; author reply 1773. PubMed ID: 23229948
    [No Abstract]   [Full Text] [Related]  

  • 52. Exertional dyspnea in chronic obstructive pulmonary disease: mechanisms and treatment approaches.
    Ora J; Jensen D; O'Donnell DE
    Curr Opin Pulm Med; 2010 Mar; 16(2):144-9. PubMed ID: 19926997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contemporary issues in refractory dyspnoea in advanced chronic obstructive pulmonary disease.
    Horton R; Rocker G
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):56-62. PubMed ID: 20407378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategies.
    Rabe KF
    Proc Am Thorac Soc; 2006 May; 3(3):270-5. PubMed ID: 16636097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxygen and helium gas mixtures for dyspnoea.
    Laude EA; Ahmedzai SH
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):91-5. PubMed ID: 18685348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morphine for management of refractory dyspnoea: opiates should be used with caution.
    Berrill JW; Linnasne SJ
    BMJ; 2003 Nov; 327(7426):1288; author reply 1288-9. PubMed ID: 14644985
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exercise.
    Calligaro GL; Raine RI; Bateman ME; Bateman ED; Cooper CB
    COPD; 2014 Feb; 11(1):105-12. PubMed ID: 24152211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
    Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
    J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endurance shuttle walking test: responsiveness to salmeterol in COPD.
    Brouillard C; Pepin V; Milot J; Lacasse Y; Maltais F
    Eur Respir J; 2008 Mar; 31(3):579-84. PubMed ID: 18057052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Better lungs for better legs: novel bronchodilator effects in COPD.
    Calverley P
    Thorax; 2010 Jul; 65(7):573-5. PubMed ID: 20627910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.